Feds investigate drug company pricing fraud allegations
Compliance Monitor, June 8, 2005
Want to receive articles like this one in your inbox? Subscribe to Compliance Monitor!
In advance of a January law that will increase government spending on prescriptions under the Medicare program, the United States has stepped up its pricing fraud investigations of some of the world's top drug manufacturers, United Press International (UPI) reported June 7.
According to the report, the U.S. government has about 150 open investigations as of June 7. If the allegations against the companies prove true, the resulting settlements could net more than $1 billion this year, UPI reported.
The government is investigating whether manufacturers are defrauding federal programs by "inflating prices, offering undisclosed rebates to distributors, or marketing drugs for unapproved uses," according to UPI. So far, investigations have resulted in fines and penalties from six major pharmaceutical manufacturers, with at least three more facing possible penalties later this year.
Want to receive articles like this one in your inbox? Subscribe to Compliance Monitor!
Related Products
-
Strategies for Health Care Compliance
News and real-life examples to increase the effectiveness of your compliance program. Strategies for Health Care Compliance...
-
Compliance Monitor
This HTML e-mail newsletter delivers news on Medicare and Medicaid fraud and abuse, as well as recent documents and targets...
-
Medicare Weekly Update
Each issue of Medicare Weekly Update includes the latest CMS proposed and final rules, CMS manual revisions, and...
-
Medicare Update for Physician Services
Medicare Update for Physician Services is a free, monthly e-zine that delivers news and information to help physician...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Identify potential Medicaid RAC target areas
- HIPAA Q&A: Level of encryption needed for email
- Topic: CMS, OESS post new security compliance review information, checklist
- Capturing all necessary codes for IUD insertion and removal can be challenging
- What does case-mix index mean to you?
- OB services: Coding inside and outside of the package
- QA:Coding multiple initial infusions
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- CMS has reformulated payments for some bilateral procedures
- HIPAA Q&A: Level of encryption needed for email
- Q&A: Follow CMS' coding guidelines when using modifier -25
- What does case-mix index mean to you?
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Q/A. One injection code or two?
- Do not code 57288 with 52000
- Searched